Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia

A 71-year-old woman complained of nausea and anorexia. Laboratory tests revealed significant neutrophilia and immunoglobulin A-kappa type M proteinemia, as well as increased plasma cells on bone marrow examination. Furthermore, the serum granulocyte-colony stimulating factor (G-CSF) concentration was high at 160 pg/ml, and the colony stimulating factor 3 receptor (CSF3R)-T618I mutation was negative. Immunohistochemical (IHC) analysis of bone marrow specimens using the anti-G-CSF antibody revealed immunopositivity of some myeloma cells. The patient was diagnosed using G-CSF-producing myeloma and was treated with daratumumab, lenalidomide, and dexamethasone. Her treatment resulted in a very good partial response, with normalization of both serum G-CSF levels and neutrophil count. There have been a few cases of G-CSF -producing myeloma reported, and it has previously been reported as chronic neutrophilic leukemia with M proteinemia. According to previous reports, techniques such as serum G-CSF measurements, IHC with an anti-G-CSF antibody, and CSF3R gene mutation analysis are useful for differentiating G-CSF-producing myeloma. However, the clinical characteristics and long-term prognosis of G-CSF-producing myeloma remain unknown. Additional case gathering and investigations are required.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:64

Enthalten in:

Rinsho ketsueki] The Japanese journal of clinical hematology - 64(2023), 8 vom: 05., Seite 735-740

Sprache:

Japanisch

Beteiligte Personen:

Yokoi, Momoko [VerfasserIn]
Kondo, Toshinori [VerfasserIn]
Shimizu, Risa [VerfasserIn]
Uchida, Keiichi [VerfasserIn]
Hayashi, Shigeki [VerfasserIn]
Nishimura, Hirotake [VerfasserIn]
Kondo, Eisei [VerfasserIn]
Wada, Hideho [VerfasserIn]

Links:

Volltext

Themen:

143011-72-7
Case Reports
English Abstract
F0P408N6V4
Granulocyte Colony-Stimulating Factor
Granulocyte-colony stimulating factor
Journal Article
Lenalidomide
Myeloma
Neutrophilia

Anmerkungen:

Date Completed 08.09.2023

Date Revised 08.09.2023

published: Print

Citation Status MEDLINE

doi:

10.11406/rinketsu.64.735

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361712707